Effectiveness of Ad26.COV2.S and BNT162b2 Vaccines against Omicron Variant in South Africa. Gray G, Collie S, Goga A, Garrett N, et al. N Engl J Med 2022 May 4. doi: 10.1056/NEJMc2202061.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Gray G, Collie S, Goga A, Garrett N, et al. Effectiveness of Ad26.COV2.S and BNT162b2 Vaccines against Omicron Variant in South Africa. N Engl J Med 2022 May 4. doi: 10.1056/NEJMc2202061.
PMID: 35507482